Dr. Alessandra Cesano Joins Zymeworks Board of Directors
Zymeworks Inc. (Nasdaq: ZYME) has appointed Dr. Alessandra Cesano to its board of directors, effective February 8, 2024, succeeding Dr....
Axalta Releases Strong Q4 and Full Year 2023 Results
Axalta Coating Systems Ltd. (NYSE: AXTA) reported robust financial results for the fourth quarter and full year ending December 31,...
I-Mab Shifts Focus; Divests Chinese Operations to Propel U.S. Biotech Ambitions
In a strategic move to bolster its presence in the U.S. biotech landscape, I-Mab (NASDAQ: IMAB), a renowned global biotech...
3M M Modal Fluency for Imaging Clinches 1 Best in KLAS Award for Fourth Consecutive Year
3M Health Information Systems (HIS) proudly announces that its cutting-edge solution, 3M M Modal Fluency for Imaging, has secured the...
BioNTech and Autolus Forge Strategic Partnership to Propel CAR-T Cell Therapy Pipeline
In a significant development within the biopharmaceutical sector, BioNTech SE and Autolus Therapeutics plc have announced a strategic collaboration aimed...
Regenxbio’s RGX-121 Trial Achieves Major Milestone in Hunter Syndrome Treatment
Regenxbio Inc. (Nasdaq: RGNX) has announced significant progress in its Phase I/II/III CAMPSIITE® trial of RGX-121 for the treatment of...
